| Literature DB >> 10937710 |
P G Nantermet1, J C Barrow, H G Selnick, C F Homnick, R M Freidinger, R S Chang, S S O'Malley, D R Reiss, T P Broten, R W Ransom, D J Pettibone, T Olah, C Forray.
Abstract
A series of alpha1a receptor antagonists derived from a 4-aryl-3,4-dihydropyridine-2-one heterocycle is disclosed. Potency in the low nanomolar to picomolar range along with high selectivity was obtained. In vivo efficacy in a prostate contraction model in rats was observed with a few derivatives.Entities:
Mesh:
Substances:
Year: 2000 PMID: 10937710 DOI: 10.1016/s0960-894x(99)00696-4
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823